Merck
MRK
$126.19
Share price
0.36%
Change (1 day)
9.72%
Change (1 year)
Categories
Merck (MRK) - Total debt
Total debt on the balance sheet as of December 2023 : $35.05 B
According to Merck's latest financial reports the company's total debt is $35.05 B. A company’s total debt is the sum of all current and non-current debts.
Merck - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $35.05 B | 14.22% |
| 2022-12-31 | $30.69 B | -7.28% |
| 2021-12-31 | $33.10 B | 4.12% |
| 2020-12-31 | $31.79 B | 20.67% |
| 2019-12-31 | $26.34 B | 4.91% |
| 2018-12-31 | $25.11 B | 2.88% |
| 2017-12-31 | $24.41 B | -1.74% |
| 2016-12-31 | $24.84 B | -5.94% |
| 2015-12-31 | $26.41 B | 23.4% |
| 2014-12-31 | $21.40 B | -14.59% |
| 2013-12-31 | $25.06 B | 21.83% |
| 2012-12-31 | $20.56 B | 17.44% |
| 2011-12-31 | $17.51 B | -2.05% |
| 2010-12-31 | $17.88 B | 2.33% |
| 2009-12-31 | $17.47 B | 180.01% |
| 2008-12-31 | $6.24 B | 8.73% |
| 2007-12-31 | $5.73 B | -16.04% |
| 2006-12-31 | $6.83 B | -15.58% |
| 2005-12-31 | $8.09 B | 17.82% |
| 2004-12-31 | $6.87 B | 1.13% |
| 2003-12-31 | $6.79 B | -20.5% |
| 2002-12-31 | $8.54 B | -3.57% |
| 2001-12-31 | $8.86 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | -16.33% | 🇺🇸 USA |
 Novartis NVS | $26.34 B | -24.84% | 🇨🇭 Switzerland |
 Pfizer PFE | $70.84 B | 102.10% | 🇺🇸 USA |
 Abbott Laboratories ABT | $15.62 B | -55.42% | 🇺🇸 USA |
 Eli Lilly LLY | $25.22 B | -28.04% | 🇺🇸 USA |
 Amgen AMGN | $64.61 B | 84.32% | 🇺🇸 USA |
 Sanofi SNY | $20.36 B | -41.90% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $41.46 B | 18.28% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $22.93 B | -34.57% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $20.15 B | -42.51% | 🇮🇱 Israel |